Bora Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	4,409	5,829	3,053	3,281	910.75	669.99
Short-Term Investments	36.73	67.86	342.63	247.62	-	-
Trading Asset Securities	20.28	20.28	-	-	-	-
Cash & Short-Term Investments	4,466	5,917	3,396	3,529	910.75	669.99
Cash Growth	-31.09%	74.25%	-3.77%	287.48%	35.94%	23.46%
Accounts Receivable	8,647	10,482	4,028	6,120	824.77	539.63
Other Receivables	333.13	954.57	82.61	286.38	33.23	186.77
Receivables	8,980	11,436	4,111	6,407	858.01	726.4
Inventory	3,220	5,502	2,157	1,991	928.64	1,112
Prepaid Expenses	723.42	591	801.43	242.47	63.07	51.33
Other Current Assets	885.59	118.63	138.63	71.58	31.87	67.01
Total Current Assets	18,275	23,566	10,604	12,241	2,792	2,627
Property, Plant & Equipment	10,937	12,510	7,494	7,300	4,067	4,158
Long-Term Investments	6,044	236.33	21.26	62.03	-	-
Goodwill	2,646	3,664	3,010	983.59	-	-
Other Intangible Assets	3,581	3,780	2,665	1,164	171.05	4.93
Long-Term Deferred Tax Assets	1,415	1,190	1,045	829.64	243.78	37.09
Other Long-Term Assets	843.16	652.74	294.85	181.01	98.65	177.22
Total Assets	43,741	45,599	25,134	22,761	7,372	7,004
Accounts Payable	824.38	792.34	380.45	454.74	235.81	219.06
Accrued Expenses	139.95	132.63	30.86	29.33	321.24	217.8
Short-Term Debt	4,071	2,598	767.51	2,161	645.48	1,218
Current Portion of Long-Term Debt	2,714	1,189	630.5	725.63	222.09	161.65
Current Portion of Leases	85.14	116.6	106.04	75.31	17.54	18.68
Current Income Taxes Payable	230.97	484.33	987.43	238.65	50.58	18.35
Current Unearned Revenue	329.16	245.6	224.6	85.69	20.47	4.11
Other Current Liabilities	5,610	8,250	5,102	6,725	327.91	428.77
Total Current Liabilities	14,005	13,809	8,229	10,496	1,841	2,286
Long-Term Debt	11,957	14,324	2,724	4,037	1,028	1,158
Long-Term Leases	724.01	745.96	763.33	596.88	305.97	325.37
Long-Term Unearned Revenue	24.62	-	-	4.18	-	-
Pension & Post-Retirement Benefits	96.65	129.04	115.36	136.41	136.28	154.85
Long-Term Deferred Tax Liabilities	971.57	1,256	783.9	742.85	609.77	202.01
Other Long-Term Liabilities	273.41	323.59	753.09	1,608	298.57	413.15
Total Liabilities	28,053	30,587	13,368	17,621	4,220	4,539
Common Stock	1,244	1,031	1,014	753.82	684.12	541.15
Additional Paid-In Capital	5,071	4,408	3,318	1,236	1,026	951.65
Retained Earnings	8,014	7,107	4,729	2,549	1,466	961.01
Treasury Stock	-58.08	-43.18	-50.97	-53.09	-	-
Comprehensive Income & Other	-639.84	364.58	74.66	42.2	-23.26	10.95
Total Common Equity	13,631	12,867	9,085	4,528	3,153	2,465
Minority Interest	2,058	2,144	2,681	612.13	-	-
Shareholders' Equity	15,689	15,012	11,766	5,140	3,153	2,465
Total Liabilities & Equity	43,741	45,599	25,134	22,761	7,372	7,004
Total Debt	19,552	18,973	4,991	7,596	2,219	2,881
Net Cash (Debt)	-15,086	-13,056	-1,595	-4,067	-1,308	-2,211
Net Cash Per Share	-111.33	-97.14	-12.84	-34.34	-11.20	-19.10
Filing Date Shares Outstanding	124.17	123.39	121.33	117.01	117.32	115.68
Total Common Shares Outstanding	124.17	123.39	121.33	117.01	117.32	115.68
Working Capital	4,269	9,757	2,375	1,745	951.22	340.48
Book Value Per Share	109.78	104.28	74.88	38.70	26.87	21.31
Tangible Book Value	7,404	5,423	3,410	2,381	2,981	2,460
Tangible Book Value Per Share	59.63	43.95	28.10	20.35	25.41	21.26
Land	3,694	3,824	3,424	3,397	1,984	2,021
Buildings	7,194	7,963	1,945	1,905	1,393	1,329
Machinery	4,418	6,113	2,814	2,390	859.79	838.14
Construction In Progress	756.63	527.38	115.84	76.72	11.73	-
Leasehold Improvements	-	-	-	205.29	-	8.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.